Tumor Uptake of (64)Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer

The goal of this study was to characterize the relationship between tumor uptake of (64)Cu-DOTA-trastuzumab as measured by PET/CT and standard, immunohistochemistry (IHC)-based, histopathologic classification of human epidermal growth factor receptor 2 (HER2) status in women with metastatic breast c...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Nucl Med
Hlavní autoři: Mortimer, Joanne E., Bading, James R., Park, Jinha M., Frankel, Paul H., Carroll, Mary I., Tran, Tri T., Poku, Erasmus K., Rockne, Russell C., Raubitschek, Andrew A., Shively, John E., Colcher, David M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Society of Nuclear Medicine 2018
Témata:
Oncology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5750523/
https://ncbi.nlm.nih.gov/pubmed/28637802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.193888
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky